Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics
Assertio Therapeutics, Inc. (ASRT)
Today's Latest Price: $0.67 USD
Updated Jan 28 9:53am
Add ASRT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 241 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ASRT Stock Summary
- With a one year PEG ratio of 0.01, Assertio Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 0.32% of US stocks.
- Over the past twelve months, ASRT has reported earnings growth of -2,343.33%, putting it ahead of only 0.91% of US stocks in our set.
- Assertio Holdings Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 709.75%, greater than the shareholder yield of 99.11% of stocks in our set.
- Stocks that are quantitatively similar to ASRT, based on their financial statements, market capitalization, and price volatility, are TACO, TRGP, IDEX, AR, and SYNL.
- ASRT's SEC filings can be seen here. And to visit Assertio Holdings Inc's official web site, go to www.assertiotx.com.
ASRT Stock Price Chart Interactive Chart >
ASRT Price/Volume Stats
| Current price | $0.67 | 52-week high | $1.71 |
| Prev. close | $0.63 | 52-week low | $0.33 |
| Day low | $0.65 | Volume | 1,075,379 |
| Day high | $0.68 | Avg. volume | 13,301,518 |
| 50-day MA | $0.47 | Dividend yield | N/A |
| 200-day MA | $0.72 | Market Cap | 76.35M |
Assertio Therapeutics, Inc. (ASRT) Company Bio
Assertio Therapeutics, Inc. (formerly DepoMed) develops products for pain and other central nervous system conditions in the United States. The company was founded in 1995 and is focused in Newark, California.
Loading social stream, please wait...